Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Sesen Bio, Inc. | ebio-123117x321.htm |
| EX-31.2 - EXHIBIT 31.2 - Sesen Bio, Inc. | ebio-123117x312.htm |
| EX-31.1 - EXHIBIT 31.1 - Sesen Bio, Inc. | ebio-123117x311.htm |
| EX-21.1 - EXHIBIT 21.1 - Sesen Bio, Inc. | ebio-123117x211.htm |
| EX-10.27 - EXHIBIT 10.27 - Sesen Bio, Inc. | ebio-ex1027decillisconsult.htm |
| EX-10.22 - EXHIBIT 10.22 - Sesen Bio, Inc. | ebio-ex1022johnjmccabe1020.htm |
| 10-K - 10-K - Sesen Bio, Inc. | ebio-123117x10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-3 No. 333-202676) of Eleven Biotherapeutics, Inc., |
(2) | Registration Statement (Post-Effective Amendment No. 1 to Form S-1 on Form S-3 No. 333-201176) of Eleven Biotherapeutics, Inc., |
(3) | Registration Statement (Form S-3 No. 333-223750) of Eleven Biotherapeutics, Inc., |
(4) | Registration Statement (Form S-1 No. 333-220809) of Eleven Biotherapeutics, Inc., |
(5) | Registration Statement (Form S-8 No. 333-202677) pertaining to the Eleven Biotherapeutics, Inc. 2014 Stock Incentive Plan, |
(6) | Registration Statement (Form S-8 No. 333-195170) pertaining to the Eleven Biotherapeutics, Inc. Amended and Restated 2009 Stock Incentive Plan, 2014 Stock Incentive Plan and 2014 Employee Stock Purchase Plan, |
(7) | Registration Statement (Form S-8 No. 333-210523) pertaining to the Eleven Biotherapeutics, Inc. 2014 Stock Incentive Plan, |
(8) | Registration Statement (Form S-8 No. 333-217686) pertaining to the Eleven Biotherapeutics, Inc. 2014 Stock Incentive Plan, and |
(9) | Registration Statement (Form S-8 No. 333-217687) pertaining to the Eleven Biotherapeutics, Inc. Inducement Stock Option Awards (September 2016); |
of our report dated April 2, 2018, with respect to the consolidated financial statements of Eleven Biotherapeutics, Inc. included in this Annual Report (Form 10-K) of Eleven Biotherapeutics, Inc. for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Boston, Massachusetts
April 2, 2018